Get started
Author

Jan Schleicher

Observed names: J Schleicher, J. Schleicher, Jan T. Schleicher, Schleicher, Jan Thomas
Observed institutions: Philipps University of Marburg, University of Münster, Universitätsklinikum Gießen und Marburg, Erasmus MC, University Hospital Heidelberg, Medizinische Hochschule Hannover, Humboldt-Universität zu Berlin, Katharinenhospital, Universitätsklinikum Tübingen, Klinikum Oldenburg, Essen University Hospital, Universitätsmedizin Rostock, Kliniken Essen-Mitte, Diakonie-Klinikum Stuttgart, Klinikum Ernst von Bergmann, Klinikum Stuttgart, Stiftung Charité, Academisch Ziekenhuis Rotterdam, University of Rostock, Freie Universität Berlin, Charité – Universitätsmedizin Berlin, University of Tübingen, Erasmus University Rotterdam
ORCID: 0000-0002-2568-8302
Observed ORCID: 0000-0002-2568-8302
OpenAlex ID: A5066991388
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
2024 · Robert J. Motzer, Camillo Porta, et al. · Journal of Clinical Oncology · 204
Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group
2003 · H.-J. Schmoll, C. Kollmannsberger, et al. · Journal of Clinical Oncology · 161
Single Versus Sequential High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Tumors: A Prospective Randomized Multicenter Trial of the German Testicular Cancer Study Group
2007 · Anja Lorch, Christian Kollmannsberger, et al. · Journal of Clinical Oncology · 144
PDF
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial
2020 · Silke Kapp-Schwoerer, Daniela Weber, et al. · Blood · 121
PDF
Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study
2019 · Richard F. Schlenk, Peter Paschka, et al. · Journal of Clinical Oncology · 113
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
2020 · Rüdiger Hehlmann, Astghik Voskanyan, et al. · Leukemia · 92
PDF
Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
2006 · Olaf Penack, Thomas Beinert, et al. · Annals of Hematology · 91
Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
2020 · Markus Ruhnke, Oliver A. Cornely, et al. · Mycoses · 79
Long term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy
1997 · J�rg Beyer, Dorothea Kingreen, et al. · Cancer · 58
PDF
High-dose chemotherapy in germ cell tumours: a large single centre experience
1998 · O Rick, J Beyer, et al. · European Journal of Cancer · 55
Phase I/II Study of Sequential Dose-Intensified Ifosfamide, Cisplatin, and Etoposide Plus Paclitaxel As Induction Chemotherapy for Poor Prognosis Germ Cell Tumors by the German Testicular Cancer Study Group
2007 · Jörg T. Hartmann, Thomas Gauler, et al. · Journal of Clinical Oncology · 46
Community-driven development of a modified progression-free survival ratio for precision oncology
2019 · Andreas Mock, Christoph E Heilig, et al. · ESMO Open · 45
PDF
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO
2005 · C. Kollmannsberger, W. Budach, et al. · Annals of Oncology · 42
PDF
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer
2002 · C Bokemeyer, K Oechsle, et al. · British Journal of Cancer · 41
PDF
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer
2004 · J. Wierecky, C. Kollmannsberger, et al. · Journal of Cancer Research and Clinical Oncology · 40
Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor
2001 · O. Rick, J. Beyer, et al. · Annals of Oncology · 40
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society
2020 · Lothar Bergmann, Viktor Grünwald, et al. · Oncology Research and Treatment · 36
PDF
Bendamustine hydrochloride in patients with refractory soft tissue sarcoma
2007 · Joerg T. Hartmann, Frank Mayer, et al. · Cancer · 36
PDF
Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarction
1990 · Wolfgang Schwartzkopff, Jan Schleicher, et al. · Atherosclerosis · 29
Role of Postchemotherapy Surgery in the Management of Patients With Liver Metastases From Germ Cell Tumors
2005 · Jörg Thomas Hartmann, Oliver Rick, et al. · Annals of Surgery · 26
Clinical Impact of Germ Cell Tumor Cells in Apheresis Products of Patients Receiving High-Dose Chemotherapy
2001 · C. Bokemeyer, A. J.M. Gillis, et al. · Journal of Clinical Oncology · 19
Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation
1998 · W Siegert, J Beyer, et al. · Bone Marrow Transplantation · 19
Immunotyping of blasts in human bone marrow
1996 · J. Oertel, B. Oertel, et al. · Annals of Hematology · 16
Mobilization of peripheral blood progenitor cells by disease-specific chemotherapy in patients with soft tissue sarcoma
1998 · N Schwella, O Rick, et al. · Bone Marrow Transplantation · 15
Detection of small numbers of immature cells in the blood of healthy subjects.
1998 · J Oertel, B Oertel, et al. · Journal of Clinical Pathology · 12
PDF
Works count: 57
Citation count: 1,640
H-index: 20
I10-index: 26
Year
Topic
Type